| Alopecia |
1 |
1 |
| Hair |
0 |
0.76 |
| Prostate Cancer |
0 |
0.49 |
| Patient Safety |
0 |
0.3 |
| Adverse Effects |
0 |
0.25 |
| Cancer |
0 |
0.25 |
| Phototherapy |
0 |
0.25 |
| Prostate |
0 |
0.25 |
| Benign Prostatic Hyperplasia |
0 |
0.23 |
| Dermatologic Surgery |
0 |
0.21 |
| Food and Drug Administration (FDA) |
0 |
0.17 |
| Hospital |
0 |
0.17 |
| Meta-Analysis |
0 |
0.99 |
| Surgery |
0 |
0.17 |
| 5-Alpha Reductase Inhibitors |
0 |
0.08 |
| Androgenetic Alopecia |
0 |
0.08 |
| Comparative Effectiveness |
0 |
0.08 |
| Fertility |
0 |
0.08 |
| Gynecomastia |
0 |
0.08 |
| Massachusetts |
0 |
0.08 |
| Pain |
0 |
0.08 |
| Tissue |
0 |
0.08 |
| Depression |
0 |
0.07 |
| Erectile Dysfunction |
0 |
0.07 |
| Pain Management |
0 |
0.07 |